BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26395199)

  • 1. The andrologist's contribution to a better life for ageing men: part 1.
    Comhaire F; Mahmoud A
    Andrologia; 2016 Feb; 48(1):87-98. PubMed ID: 26395199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and longevity.
    Comhaire F
    Andrologia; 2016 Feb; 48(1):65-8. PubMed ID: 25892327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
    Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
    Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials.
    Nian Y; Ding M; Hu S; He H; Cheng S; Yi L; Li Y; Wang Y
    Andrologia; 2017 May; 49(4):. PubMed ID: 27389320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The andrologist's contribution to a better life for ageing men: part 2.
    Comhaire F; Mahmoud A
    Andrologia; 2016 Feb; 48(1):99-110. PubMed ID: 26395368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy.
    Ide V; Vanderschueren D; Antonio L
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
    Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging medication for the treatment of male hypogonadism.
    Aydogdu A; Swerdloff RS
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset hypogonadism a challenging task for the andrology field.
    Corona G; Krausz C
    Andrology; 2020 Nov; 8(6):1504-1505. PubMed ID: 33460316
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel androgen therapies including selective androgen receptor modulators.
    Kang J; Chen R; Tharakan T; Minhas S
    Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101686. PubMed ID: 35981955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan.
    Shigehara K; Konaka H; Koh E; Izumi K; Kitagawa Y; Mizokami A; Nakashima T; Shimamura M; Iwamoto T; Namiki M
    Aging Male; 2015; 18(3):169-74. PubMed ID: 26075538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
    Amano T
    Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.